Condition: Ovarian Neoplasms · Sponsor: Cleo Diagnostics Ltd
Ovarian cancer is a serious health risk with the highest death rate among gynecological cancers. Unfortunately, it's only possible to definitively diagnose ovarian cancer after surgery, as there are no reliable tests to determine if an ovarian abnormality is cancerous or benign before surgery. Cleo Diagnostics have developed a new test that uses five biomarkers in the blood to better differentiate between benign and malignant ovarian conditions. In initial studies, this test outperformed the current standard test, CA125, in identifying cancer. This study aims to evaluate the effectiveness of the Cleo Diagnostics (CleoDX) Ovarian Adnexal Mass Score Test System. This test measures five analytes in the blood and provides a score indicating the likelihood of cancer in patients with an adnexal mass requiring surgery. The test is designed to assist doctors in making better-informed decisions about surgery and patient care by providing a more accurate pre-surgical assessment of cancer risk. By doing so, it aims to improve patient outcomes and ensure that those with malignant conditions receive the appropriate specialist care.
This description comes directly from the study's public registry record.
Assoc. Director of Operations Assoc. Director of Operations · 1-855-264-4064 · cleo_csp01001@lindushealth.com
Trial Coordinator · 1-855-264-4064 · cleo_csp01001@lindushealth.com
Always discuss trial participation with your own doctor first.
| New Horizons Clinical Trials | Chandler, Arizona, United States | Recruiting |
| Emerald Coast Clinical Research | Panama City, Florida, United States | Recruiting |
| Women's Cancer Center of Nevada | Las Vegas, Nevada, United States | Recruiting |
| The Jackson Clinic | Jackson, Tennessee, United States | Recruiting |
| Next Innovative Clinical Research | Houston, Texas, United States | Recruiting |
| Prime Clinical Research - Lewisville | Lewisville, Texas, United States | Recruiting |
| Vast Clinical Research-Holy Cross | Mesquite, Texas, United States | Recruiting |
| Virginia Women's Health Associates | Annandale, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06566716